Tag Archives: AVAC

AVAC: HIV vaccine, microbicides, PrEP trial results say reality must guide research

By on .

For all the graphics illustrating results of HIV prevention trials in recent years, the Venn diagram on the cover of Research & Reality, the report released by AVAC today, may be the one that depicts the sum of their findings. Which is really saying something, when one considers the up-and-down nature of prevention research results […]

PEPFAR Act assures five more years of U.S. HIV, TB responses

By on .

Bipartisan, bicameral legislation extends U.S. Leadership Act, confirming ongoing commitments to PEPFAR and the Global Fund Proving that Congress can act, unified, swiftly and decisively, the United States Senate Monday unanimously passed legislation renewing authorization of the President’s Emergency Plan For AIDS Relief, and supporting the program’s goals. The PEPFAR Stewardship and Oversight Act of […]

Clinician scientists urge support for PEPFAR bill, while we’re reading about the high stakes of the U.S. global health response

By on .

Update — The PEPFAR Stewardship and Oversight Bill of 2013: In spite of the government shutdown, hopes were high in the beginning of the month that the Senate would take action on a bill to extend the the United States global AIDS response. Senate Foreign Relations Committee leaders Robert Menendez and Bob Corker introduced S […]

Report shows U.S. HIV research investment, progress; projects lasting impact from cuts

By on .

With the United States funding 70 percent of the world’s research and development of biomedical answers to HIV prevention, progress that has yielded the potential for immediate advances against the global epidemic is in danger of stalling, with lasting consequences, according to a report released at the International AIDS Society conference in Kuala Lumpur this […]

New WHO guidelines for HIV treatment would begin to narrow care gap between rich and poor countries

By on .

WHO: Comprehensive guidelines to start treatment earlier in illness and, for some, immediately, would make 26 million people eligible for medicine, avert 3 million deaths, prevent more than 3 million infections Calling for more widespread access to antiretroviral medicine worldwide in updated HIV treatment guidelines released Sunday, the World Health Organization acknowledged the changes will […]

With study of injecting drug users, preventive HIV medicine demonstrates protective value to all at high risk

By on .

CDC releases updated Guidance for Pre-Exposure Prophylaxis for the Prevention of HIV Infection: PrEP for Injecting Drug Users, while questions on real-world impact remain With a five-year study in Bangkok showing that daily doses of antiretroviral medicine reduced risks of HIV infection among people who inject drugs by at least half, and more with the […]

Physicians, researchers, advocates tell Obama and Congress: Gaps in President’s budget request will reverse gains

By on .

Three weeks after President Obama’s budget proposal for fiscal year 2014 appeared, sustaining support for the Global Fund to Fight AIDS Tuberculosis and Malaria, while cutting funds to the President’s Emergency Plan For AIDS Relief, and hacking global TB funding, physicians, scientists, and global health advocates are weighing in. And while United States Agency for […]

HVTN 505 Investigator: “We’ve got to keep moving the stone up the hill”

By on .

A week to the day after a monitoring board told organizers of the clinical vaccine research trial known as HVTN 505 to stop inoculating participants, only a few certainties have surfaced. One is that the would be vaccine regimen did not prevent HIV infections. The other is that the search for an effective vaccine will […]

Disappointing vaccine trial news, key populations, PEPFAR blueprint all part of Jhpiego’s “The Present and the Future of HIV Prevention”

By on .

A chart of clinical research trials seeking ways to control HIV transmission makes for an impressive display of tenacity, with interrupted trials, ongoing trials, trials that led to other trials, and new trials in their earliest stages. It includes trials of microbicides, vaccines, antiretroviral-drug-based approaches and all of that in different combinations. It includes heartening […]

The cost of cutting PEPFAR, What VOICE did tell us, and answers to other pressing questions . . .

By on .

If we want an AIDS-free generation, why are we cutting PEPFAR? The Obama administration’s budget request for fiscal year 2014, which includes a fourth consecutive cut to funding for the President’s Emergency Plan For AIDS Relief that would bring the program to its lowest funding level since 2007, raises questions, this piece by amfAR public […]